“It is a great honor that our president & CEO Dr Zhang Dan has been invited as consultant by CDE. Per invitation he gave an important presentation in CDE seminar of innovative drug R & D, Shanghai 2009. Hereby CDE express high appreciation of his work with the thanking letter. ”
"The new version has expanded significantly" It clearly spells out the reporting timeline for death case, as well as AE and SAEs. It also clearly identifies the role/responsibilities of city level, provincial level and SFDA in handling AE and SAE cases. ¡° For detail information on the new regulation and its impact on conducting clinical trials in China. Please contact FMD for one-on-one consultation.
USA Joanne Jiang, Ph.D., MBA Fountain Medical Development Tel: 732-447-6898 Email:joanne.jiang@fountain-med.com